Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A round totals $33mm for Flexion Therapeutics, which adds more later

Executive Summary

Drug development start-up Flexion Therapeutics has completed a $33mm Series A financing led by Versant Ventures, which also took part in the company's $3mm seed round in November 2007. Other founding investors participating in this round were 5AM Ventures and Sofinnova Partners. With a business model based on Lilly Research Lab division Chorus, Flexion hopes to take candidates through proof-of-concept faster and cheaper than the traditional development process. The company expects to soon announce partnerships it has in the works with three as-yet-unannounced pharmacos.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies